Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y, Enhanced phosphorylation of p53 by ATM in response to DNA damage Science 281: 1674–1677, 1998 ArticlePubMedCAS Google Scholar
el Deiry WS, Harper JW, O’Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res 54: 1169–1174, 1994 PubMed Google Scholar
Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ, Radiation-induced cell cycle arrest compromised by p21 deficiency Nature 377: 552–557, 1995 ArticlePubMedCAS Google Scholar
Walker KK, Levine AJ, Identification of a novel p53 functional domain that is necessary for efficient growth suppression Proc Natl Acad Sci USA 93: 15335–15340, 1996 ArticlePubMedCAS Google Scholar
Lazar V, Hazard F, Bertin F, Janin N, Bellet D, Bressac B, Simple sequence repeat polymorphism within the p53 gene Oncogene 8: 1703–1705, 1993 PubMedCAS Google Scholar
Chedid M, Michieli P, Lengel C, Huppi K, Givol D, A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1 Oncogene 9: 3021–3024, 1994 PubMedCAS Google Scholar
Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, Kadlubar FF, Spitz MR, p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity J Natl Cancer Inst 94: 681–690, 2002 PubMedCAS Google Scholar
Powell BL, van Staveren IL, Roosken P, Grieu F, Berns EM, Iacopetta B, Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer Carcinogenesis 23: 311–315, 2002 ArticlePubMedCAS Google Scholar
Wang-Gohrke S, Becher H, Kreienberg R, Runnebaum IB, Chang-Claude J, Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years Pharmacogenetics 12: 269–272, 2002 ArticlePubMedCAS Google Scholar
Gemignani F, Moreno V, Landi S, Moullan N, Chabrier A, Gutierrez-Enriquez S, Hall J, Guino E, Peinado MA, Capella G, Canzian F, A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA Oncogene 23: 1954–1956, 2004 ArticlePubMedCAS Google Scholar
Wu MT, Wu DC, Hsu HK, Kao EL, Yang CH, Lee JM, Association between p21 codon 31 polymorphism and esophageal cancer risk in a Taiwanese population Cancer Lett 201: 175–180, 2003 ArticlePubMedCAS Google Scholar
Roh JW, Kim JW, Park NH, Song YS, Park IA, Park SY, Kang SB, Lee HP, p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer Gynecol Oncol 93: 499–505, 2004 ArticlePubMedCAS Google Scholar
Roh J, Kim M, Kim J, Park N, Song Y, Kang S, Lee H, Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women Cancer Lett 165: 59–62, 2001 ArticlePubMedCAS Google Scholar
Huang SP, Wu WJ, Chang WS, Wu MT, Chen YY, Chen YJ, Yu CC, Wu TT, Lee YH, Huang JK, Huang CH, p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer Cancer Epidemiol Biomarkers Prev 13: 2217–2224, 2004 PubMedCAS Google Scholar
Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G, Two polymorphic variants of wild-type p53 differ biochemically and biologically Mol Cell Biol 19: 1092–1100, 1999 PubMedCAS Google Scholar
Dumont P, Leu JI, Della PA III, George DL, Murphy M, The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 33: 357–365, 2003 ArticlePubMedCAS Google Scholar
Pim D, Banks L, p53 polymorphic variants at codon 72 exert different effects on cell cycle progression Int J Cancer 108: 196–199, 2004 ArticlePubMedCAS Google Scholar
Twardella D, Popanda O, Helmbold I, Ebbeler R, Benner A, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J, Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy Radiother Oncol 69: 145–153, 2003 ArticlePubMedCAS Google Scholar
Cancer Therapy Evaluation Program. Common Toxicity Criteria. NIH 1998, http://ctep.cancer.gov /reporting/ctc.html
Popanda O, Ebbeler R, Twardella D, Helmbold I, Gotzes F, Schmezer P, Thielmann HW, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Bartsch H, Chang-Claude J, Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy Int J Radiat Oncol Biol Phys 55: 1216–1225, 2003 ArticlePubMed Google Scholar
Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB, p53 germline polymorphisms are associated with an increased risk for breast cancer in German women Anticancer Res 18: 2095–2099, 1998 PubMedCAS Google Scholar
Boltze C, Roessner A, Landt O, Szibor R, Peters B, Schneider-Stock R, Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma Int J Oncol 21: 1151–1154, 2002 PubMedCAS Google Scholar
Xie X, Ott J, Testing linkage disequilibrium between a disease gene and marker loci Am J Hum Genet 53:1107–1110, 1993 PubMed Google Scholar
Terwilliger J, Ott J, Handbook of Human Genetic Linkage Johns Hopkins University Press Baltimore, 1994 Google Scholar
Stephens M, Donnelly P, A comparison of Bayesian methods for haplotype reconstruction from population genotype data Am J Hum Genet 73: 1162–1169, 2003 ArticlePubMedCAS Google Scholar
Keshava C, Frye BL, Wolff MS, McCanlies EC, Weston A, Waf-1 (p21) and p53 polymorphisms in breast cancer Cancer Epidemiol Biomarkers Prev 11: 127–130, 2002 PubMedCAS Google Scholar
Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X, Crook T, Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo Oncogene 23: 3328–3337, 2004 ArticlePubMedCAS Google Scholar
Komarova EA, Kondratov RV, Wang K, Christov K, Golovkina TV, Goldblum JR, Gudkov AV, Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice Oncogene 23: 3265–3271, 2004 ArticlePubMedCAS Google Scholar
Dewey WC, Ling CC, Meyn RE, Radiation-induced apoptosis: relevance to radiotherapy Int J Radiat Oncol Biol Phys 33: 781–796, 1995 ArticlePubMedCAS Google Scholar
Dorr W, Modulation of repopulation processes in oral mucosa: experimental results Int J Radiat Biol 79: 531–537, 2003 ArticlePubMedCAS Google Scholar
Hopewell JW, Nyman J, Turesson I, Time factor for acute tissue reactions following fractionated irradiation: a balance between repopulation and enhanced radiosensitivity Int J Radiat Biol 79: 513–524, 2003 ArticlePubMedCAS Google Scholar
Matsuzoe D, Hideshima T, Kimura A, Inada K, Watanabe K, Akita Y, Kawahara K, Shirakusa T, p53 mutations predict non-small cell lung carcinoma response to radiotherapy Cancer Lett 135: 189–194, 1999 ArticlePubMedCAS Google Scholar
Mazzatti DJ, Lee YJ, Helt CE, O’Reilly MA, Keng PC, p53 modulates radiation sensitivity independent of p21 transcriptional activation Am J Clin Oncol 28: 43–50, 2005 ArticlePubMed Google Scholar
Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Ambrosone CB, Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients Clin Cancer Res 11: 4802–4809, 2005 ArticlePubMedCAS Google Scholar
Bentzen SM, Overgaard M, Relationship between early and late normal-tissue injury after postmastectomy radiotherapy Radiother Oncol 20: 159–165, 1991 ArticlePubMedCAS Google Scholar